Dipal Mehta, Samah Alimam, Donal P McLornan, John A Henry, Syeda Ahmed, Arjun K Ghosh, Sara Tyebally, John M Walker, Riyaz Patel, Rodothea Amerikanou, Jenny O'Nions, Andrew J Wilson, Jon Lambert, Mallika Sekhar, Daniel Chen
BACKGROUND: Myeloproliferative neoplasms (MPNs) are a group of disorders of clonal haemopoiesis associated with an inherent risk of arterial and venous thrombotic complications. The prevalence of thrombotic complications and the impact of cardiovascular risk factors (CVRFs) in contemporary patient cohorts within the current era of MPN treatments have not been completely defined. OBJECTIVES: We aim to characterise the cardiovascular risk of patients with MPN by identifying the prevalence of CVRFs and describing the pattern of thrombotic events...
October 13, 2023: Current Research in Translational Medicine